Cinci, Marc <br/><br/>
Targeted delivery of siRNA using transferrin-coupled lipoplexes specifically sensitizes CD71 high expressing malignant cells to antibody-mediated complement attack.  [electronic resource] 

 -  Targeted oncology  Sep 2015 
 - 405-13 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1776-260X 
<br/><br/><label>Standard No.: </label>10.1007/s11523-014-0345-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies--chemistry<br/>Antigens, CD--genetics<br/>CD55 Antigens--metabolism<br/>CD59 Antigens--metabolism<br/>Cell Line, Tumor<br/>Complement C3--metabolism<br/>Complement System Proteins<br/>Down-Regulation<br/>Female<br/>Flow Cytometry<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Immunotherapy--methods<br/>Male<br/>Membrane Cofactor Protein--metabolism<br/>RNA, Messenger--metabolism<br/>RNA, Small Interfering--metabolism<br/>Receptors, Transferrin--genetics<br/>Transferrin--metabolism